@su2cscience.bsky.social
In a wide-ranging #SU2CInnovationSummit, scientists from many different fields discussed methods, technologies, and systems for catching cancers at their earliest stages and selecting the best treatments for every patient. #StandUpToCancer
February 1, 2026 at 2:15 AM
In a wide-ranging #SU2CInnovationSummit, scientists from many different fields discussed methods, technologies, and systems for catching cancers at their earliest stages and selecting the best treatments for every patient. #StandUpToCancer
Another #SU2CInnovationSummit was focused on developing novel approaches for detecting and treating brain cancers called gliomas. #StandUpToCancer
February 1, 2026 at 1:46 AM
Another #SU2CInnovationSummit was focused on developing novel approaches for detecting and treating brain cancers called gliomas. #StandUpToCancer
In a #SU2CInnovationSummit held today, researchers reviewed the latest data on the surge in early-onset cancers and discussed potential approaches for improving early detection and treatment of cancer in these younger patients. #StandUpToCancer
February 1, 2026 at 1:13 AM
In a #SU2CInnovationSummit held today, researchers reviewed the latest data on the surge in early-onset cancers and discussed potential approaches for improving early detection and treatment of cancer in these younger patients. #StandUpToCancer
Researchers at the #SU2CScientificSummit gave us their one-word descriptions of #StandUpToCancer. Each word and phrase is a testament to our mission: Raise awareness and fund research to detect and treat cancers with the aspiration to cure all patients. 💛
January 31, 2026 at 6:58 PM
Researchers at the #SU2CScientificSummit gave us their one-word descriptions of #StandUpToCancer. Each word and phrase is a testament to our mission: Raise awareness and fund research to detect and treat cancers with the aspiration to cure all patients. 💛
Thank you to our wonderful keynote speakers, #StandUpToCancer Prostate Cancer Dream Team leader Dr. Arul Chinnaiyan and SU2C Science Advisory Committee Vice Chair Dr. John Carpten. #SU2CScientificSummit
January 30, 2026 at 11:23 PM
Thank you to our wonderful keynote speakers, #StandUpToCancer Prostate Cancer Dream Team leader Dr. Arul Chinnaiyan and SU2C Science Advisory Committee Vice Chair Dr. John Carpten. #SU2CScientificSummit
A full day has begun at the #SU2CScientificSummit! We received inspiring remarks from #StandUpToCancer President and CEO Dr. Julian Adams, SU2C Science Advisory Committee Chair Dr. William G. Nelson, @theaacr.bsky.social CEO Dr. Marge Foti, and SU2C co-founder Sherry Lansing.
January 30, 2026 at 6:28 PM
A full day has begun at the #SU2CScientificSummit! We received inspiring remarks from #StandUpToCancer President and CEO Dr. Julian Adams, SU2C Science Advisory Committee Chair Dr. William G. Nelson, @theaacr.bsky.social CEO Dr. Marge Foti, and SU2C co-founder Sherry Lansing.
The other #SU2CInnovationSummit held today was a collaboration with the Farrah Fawcett Foundation, gathering researchers, advocates, & other stakeholders to chart a path forward for the early detection, screening, and treatment of HPV-related anal and oropharyngeal cancers. #StandUpToCancer
January 30, 2026 at 1:46 AM
The other #SU2CInnovationSummit held today was a collaboration with the Farrah Fawcett Foundation, gathering researchers, advocates, & other stakeholders to chart a path forward for the early detection, screening, and treatment of HPV-related anal and oropharyngeal cancers. #StandUpToCancer
In one #SU2CInnovationSummit held today, leading researchers discussed advances in cancer theranostics. Theranostics are like multitalented homing beacons: Molecules that allow doctors to clearly see tumors with imaging, like a PET scan, and that can also precisely deliver radiation to those tumors.
January 30, 2026 at 1:16 AM
In one #SU2CInnovationSummit held today, leading researchers discussed advances in cancer theranostics. Theranostics are like multitalented homing beacons: Molecules that allow doctors to clearly see tumors with imaging, like a PET scan, and that can also precisely deliver radiation to those tumors.
The #SU2CScientificSummit and five #SU2CInnovationSummits are taking place this week in Pasadena, California! Hundreds of scientists will be discussing the latest in cancer research and treatment, and identifying opportunities for rapid progress. Let the innovation begin! #StandUpToCancer
January 29, 2026 at 4:41 PM
The #SU2CScientificSummit and five #SU2CInnovationSummits are taking place this week in Pasadena, California! Hundreds of scientists will be discussing the latest in cancer research and treatment, and identifying opportunities for rapid progress. Let the innovation begin! #StandUpToCancer
Dr. Julian Adams, President and CEO of @su2c.bsky.social, is at the @milkeninstitute.org today discussing innovations in #EarlyDetection and equitable cancer care. Panelists include @boehmjesse.bsky.social from @break-cancer.bsky.social, Ian Foulkes from @cancerresearchuk.org, and Maddie Musselman
November 6, 2025 at 10:20 PM
Dr. Julian Adams, President and CEO of @su2c.bsky.social, is at the @milkeninstitute.org today discussing innovations in #EarlyDetection and equitable cancer care. Panelists include @boehmjesse.bsky.social from @break-cancer.bsky.social, Ian Foulkes from @cancerresearchuk.org, and Maddie Musselman
Last week, Dr. Julian Adams, President and CEO of @su2c.bsky.social, spoke at the #LongwoodHealthcareLeaders #BostonCEO 2025. The event covered a wide range of topics, including health equity and patient access to care. It was attended by top leaders in healthcare and select Nobel Laureates.
November 6, 2025 at 3:20 PM
Last week, Dr. Julian Adams, President and CEO of @su2c.bsky.social, spoke at the #LongwoodHealthcareLeaders #BostonCEO 2025. The event covered a wide range of topics, including health equity and patient access to care. It was attended by top leaders in healthcare and select Nobel Laureates.
Will Freed-Pastor from @danafarber.bsky.social gave a phenomenal presentation on cryptic #antigens and their potential as targets for TCR-based therapies at the @theaacr.bsky.social Special Conference in #PancreaticCancer Research.
October 8, 2025 at 7:42 PM
Will Freed-Pastor from @danafarber.bsky.social gave a phenomenal presentation on cryptic #antigens and their potential as targets for TCR-based therapies at the @theaacr.bsky.social Special Conference in #PancreaticCancer Research.
The 18th @theaacr.bsky.social Conference on the Science of #HealthDisparities took place in Baltimore from September 18-21. A special session held on Saturday featured a panel discussion, grantees, advocates, and other members of the @su2c.bsky.social community. Thanks to all in attendance!
September 22, 2025 at 3:38 PM
The 18th @theaacr.bsky.social Conference on the Science of #HealthDisparities took place in Baltimore from September 18-21. A special session held on Saturday featured a panel discussion, grantees, advocates, and other members of the @su2c.bsky.social community. Thanks to all in attendance!
The Data for Children's and Young People's Cancer Programme Award is a new partnership between @su2c.bsky.social and @cancerresearchuk.org to support data-driven solutions to common challenges in this space.
More information: cruk.ink/4njVxWU
Informational webinar: cruk.ink/4gdAcw9
More information: cruk.ink/4njVxWU
Informational webinar: cruk.ink/4gdAcw9
September 12, 2025 at 4:14 PM
The Data for Children's and Young People's Cancer Programme Award is a new partnership between @su2c.bsky.social and @cancerresearchuk.org to support data-driven solutions to common challenges in this space.
More information: cruk.ink/4njVxWU
Informational webinar: cruk.ink/4gdAcw9
More information: cruk.ink/4njVxWU
Informational webinar: cruk.ink/4gdAcw9
Check out the upcoming New York Academy of Sciences Frontiers in Cancer Immunology Symposium. The event features several current and former @SU2C – funded researchers including @bengrbm.bsky.social, Jim Allison, Antoni Ribas, Taha Merghoub, and Padmanee Sharma. #immunology #cancer
June 9, 2025 at 6:52 PM
Check out the upcoming New York Academy of Sciences Frontiers in Cancer Immunology Symposium. The event features several current and former @SU2C – funded researchers including @bengrbm.bsky.social, Jim Allison, Antoni Ribas, Taha Merghoub, and Padmanee Sharma. #immunology #cancer
Gerrit Meijer from the @su2cscience.bsky.social-#KWF MEDOCC team presented the Team’s work in developing the multi-target FIT test for colorectal cancer at the @nkinl.bsky.social Early Cancer Detection Conference #StandUpToCancer #NetherlandsCancerInstitute #colorectalcancer
May 15, 2025 at 12:45 PM
Gerrit Meijer from the @su2cscience.bsky.social-#KWF MEDOCC team presented the Team’s work in developing the multi-target FIT test for colorectal cancer at the @nkinl.bsky.social Early Cancer Detection Conference #StandUpToCancer #NetherlandsCancerInstitute #colorectalcancer
In February, members of the #StandUpToCancer - Van Andel Institute #Epigenetics Dream Team, Ben Youngblood from St. Jude Children's Research Hospital, and Kirsten Grønbaek from Rigshospitalet, presented at the AACR DNA #Methylation, Clonal Hematopoiesis, and #Cancer Special Conference in San Diego.
March 27, 2025 at 1:35 PM
In February, members of the #StandUpToCancer - Van Andel Institute #Epigenetics Dream Team, Ben Youngblood from St. Jude Children's Research Hospital, and Kirsten Grønbaek from Rigshospitalet, presented at the AACR DNA #Methylation, Clonal Hematopoiesis, and #Cancer Special Conference in San Diego.
We were honored to hear from keynote speakers Drs. Trey Ideker, Melissa Davis, Kevan Shokat, & Mark McClellan who each presented at the virtual #StandUpToCancer Community Gathering. Topics were AI in cancer research, cancer inequities, KRAS mutation, healthcare reform, & more.
January 25, 2025 at 7:51 PM
We were honored to hear from keynote speakers Drs. Trey Ideker, Melissa Davis, Kevan Shokat, & Mark McClellan who each presented at the virtual #StandUpToCancer Community Gathering. Topics were AI in cancer research, cancer inequities, KRAS mutation, healthcare reform, & more.
Today, our #StandUpToCancer researchers met virtually to discuss the latest in cutting-edge science & share their progress at the SU2C Community Gathering. As SU2C President & CEO Dr. Julian Adams says, we have no doubt in our goal to save more lives from this terrible disease. 💪
January 25, 2025 at 7:28 PM
Today, our #StandUpToCancer researchers met virtually to discuss the latest in cutting-edge science & share their progress at the SU2C Community Gathering. As SU2C President & CEO Dr. Julian Adams says, we have no doubt in our goal to save more lives from this terrible disease. 💪